Advertisement

Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation

  • Maayan Shiner
    Affiliations
    Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel
    Search for articles by this author
  • Bianca Fuhrman
    Correspondence
    Corresponding author. Tel.: +972 4 8295278; fax: +972 4 8520076.
    Affiliations
    Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel
    Search for articles by this author
  • Michael Aviram
    Affiliations
    Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel
    Search for articles by this author

      Abstract

      Paraoxonase 2 (PON2), a member of the paraoxonase gene family, was shown to protect macrophages against oxidative stress. Pomegranate juice (PJ), which contains potent polyphenol anti-oxidants, exhibits similar effects. We questioned possible association between PJ polyphenolics, macrophage oxidative stress, and cellular PON2 expression, in relation to the activation of specific PON2 transcription factors. Incubation of J774A.1 macrophages with PJ (0–50 μM of total polyphenols) dose-dependently increased expression (mRNA, protein) and activity and reduced macrophage oxidative status. These effects could be attributed to the PJ unique polyphenols, punicalagin and gallic acid. PJ polyphenol-induced up-regulation of PON2 was inhibited by 40% upon using the PPARγ inhibitor GW9662 (50 μM). Accordingly, the PPARγ ligand, rosiglitazone, dose-dependently stimulated macrophage PON2 expression, by up to 80%. Inhibition of AP-1 activation with SP600125, attenuated PJ-induced up-regulation of PON2 by 40%. Similarly, incubation of macrophages with PJ polyphenols in the presence of GW9662 or SP600125, significantly reduced their capacity to protect the cells against oxidative stress. We conclude that the anti-oxidative characteristics of PJ unique phenolics punicalagin and gallic acid could be related, at least in part, to their stimulatory effect on macrophage PON2 expression, a phenomenon which was shown to be associated with activation of the transcription factors PAPRγ and AP-1.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kovacic P.
        • Thurn L.A.
        Cardiovascular toxicity from the perspective of oxidative stress, electron transfer, and prevention by antioxidants.
        Curr Vasc Pharmacol. 2005; 3: 107-117
        • Schulze P.C.
        • Lee R.T.
        Oxidative stress and atherosclerosis.
        Curr Atheroscler Rep. 2005; 7: 242-248
        • Kaplan M.
        • Hayek T.
        • Raz A.
        • et al.
        Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis.
        J Nutr. 2001; 131: 2082-2089
        • Aviram M.
        • Dornfeld L.
        • Rosenblat M.
        • et al.
        Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice.
        Am J Clin Nutr. 2000; 71: 1062-1076
        • Rosenblat M.
        • Volkova N.
        • Colemna R.
        • Aviram M.
        Pomegranate byproduct administration to apolipoprotein E-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein.
        J Agric Food Chem. 2006; 54: 1928-1935
        • Rosenblat M.
        • Hayek T.
        • Aviram M.
        Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages.
        Atherosclerosis. 2006; 187: 363-371
        • Fuhrman B.
        • Volkova N.
        • Aviram M.
        Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages.
        J Nutr Biochem. 2005; 16: 570-576
        • Rozenberg O.
        • Howell A.
        • Aviram M.
        Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it.
        Atherosclerosis. 2006; 188: 68-76
        • De Nigris F.
        • Williams-Ignarro S.
        • Lerman L.O.
        • et al.
        Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress.
        Proc Natl Acad Sci USA. 2005; 102: 4896-4901
        • Xia M.
        • Hou M.
        • Zhu H.
        • et al.
        Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway.
        J Biol Chem. 2005; 280: 36792-36801
        • Huang T.H.
        • Peng G.
        • Kota B.P.
        • et al.
        Anti-diabetic action of punica granatum flower extract: activation of PPAR-gamma and identification of an active component.
        Toxicol Appl Pharmacol. 2005; 207: 160-169
        • Ng C.J.
        • Wadleigh D.J.
        • Gangopadhyay A.
        • et al.
        Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
        J Biol Chem. 2001; 276: 44444-44449
        • Rosenblat M.
        • Draganov D.
        • Watson C.E.
        • et al.
        Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress.
        Arterioscler Thromb Vasc Biol. 2003; 23: 468-474
        • Shiner M.
        • Fuhrman B.
        • Aviram M.
        Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.
        Free Radic Biol Med. 2004; 37: 2052-2063
        • Shiner M.
        • Fuhrman B.
        • Aviram M.
        A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity.
        Biochem Biophys Res Commun. 2006; 349: 1094-1099
        • Buege J.A.
        • Aust S.D.
        Microsomal lipid peroxidation.
        Methods Enzymol. 1978; 52: 302-310
        • Shamir R.
        • Hartman C.
        • Karry R.
        • et al.
        Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2.
        Free Radic Biol Med. 2005; 39: 336-344
        • Kulkarni A.P.
        • Aradhya S.M.
        • Divakar S.
        Isolation and identification of a radical scavenging antioxidant—punicalagin from pith and carpellary membrane of pomegranate fruit.
        Food Chem. 2004; 87: 551-557
        • Reddy S.T.
        • Wadleigh D.J.
        • Grijalva V.
        • et al.
        Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
        Arterioscler Thromb Vasc Biol. 2001; 21: 542-547
        • Aviram M.
        • Rosenblat M.
        • Billecke S.
        • et al.
        Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
        Free Radic Biol Med. 1999; 26: 892-904
        • Aviram M.
        • Rosenblat M.
        • Bisgaier C.L.
        • et al.
        Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase.
        J Clin Invest. 1998; 101: 1581-1590
        • Abdelrahman M.
        • Sivarajah A.
        • Thiemermann C.
        Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
        Cardiovasc Res. 2005; 65: 772-781
        • Koutsogiannaki S.
        • Evangelinos N.
        • Koliakos G.
        • Kaloyianni M.
        Cytotoxic mechanisms of Zn2+ and Cd2+ involve Na+/H+ exchanger (NHE) activation by ROS.
        Aquat Toxicol. 2006; 78: 315-324
        • Pham H.
        • Banerjee T.
        • Nalbandian G.M.
        • Ziboh V.A.
        Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by 15S-hydroxyeicosatrienoic acid parallels growth suppression of androgen-dependent prostatic adenocarcinoma cells.
        Cancer Lett. 2003; 189: 17-25
        • Smeal T.
        • Binetruy B.
        • Mercola D.
        • et al.
        Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.
        Mol Cell Biol. 1992; 12: 3507-3513
        • Nieminen R.
        • Lahti A.
        • Jalonen U.
        • Kankaanranta H.
        • Moilanen E.
        JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages.
        Int Immunopharmacol. 2006; 6: 987-996
        • Ricote M.
        • Li A.C.
        • Willson T.M.
        • Kelly C.J.
        • Glass C.K.
        The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.
        Nature. 1998; 391: 79-82
        • Subbaramaiah K.
        • Lin D.T.
        • Hart J.C.
        • Dannenberg A.J.
        Peroxisome proliferator-activated receptor γ ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and creb-binding protein/p300.
        J Biol Chem. 2001; 276: 12440-12448
        • Uchimura K.
        • Nakamuta M.
        • Enjoji M.
        • et al.
        Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.
        Hepatology. 2001; 33: 91-99
        • Marra F.
        • Efsen E.
        • Romanelli R.G.
        • et al.
        Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.
        Gastroenterology. 2000; 119: 466-478